The North West of England Endocrinology, Diabetes and Obesity Newsletter

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 15 other followers

  • Search site

  • Calendar

    January 2014
    M T W T F S S
    « Dec   Mar »
  • Categories

  • Comments

  • Advertisements

UK National Lipoprotein Apheresis Conference on 7th March 2014

Posted by Safwaan Adam on 16 January, 2014

2014 UK National Lipoprotein Apheresis Conference

7th March 2014, 09:00-1600


Venue: Hilton Manchester Airport Hotel,

Manchester Airport, Outwood Lane, Manchester,  M90 4WP

CPD accreditation: 5 CPD applied for


0920-0930  Welcome: Dr Handrean Soran

  Session 1

0930-1010  Underestimation of the importance of LDL-cholesterol lowering in   cardiovascular disease prevention in current practice. Professor Paul   Durrington, Professor of Medicine, University of Manchester, UK.

1010-1050  Lipoprotein (a) as a cardiovascular risk factor: review of evidence and   therapeutic options. Dr Dermot Neely, Consultant in Clinical Biochemistry   and Metabolic Medicine, Royal Victoria Infirmary, Newcastle, UK.

1050-1120   Coffee and networking

  Session 2

1120-1200  HoFH; is it just double trouble? The role of the LDL-receptor in lipid   metabolism and implications for therapeutic options. Dr Michael France,   Consultant Chemical Pathologist, Central Manchester University Hospitals   NHS Foundation Trust, Manchester, UK.

1200-1240  Lipoprotein Apheresis: who and how should we treat? Dr Dev Datta,   University Hospital Cardiff, Cardiff, UK.

1240-1350  Lunch

  Session 3

1350-1430  Lomitapide as a therapeutic option for HoFH. Professor Claudia Stefanutti,   Professor of Internal Medicine, Extracorporeal Therapeutic Techniques   Unit – Lipid Clinic and Atherosclerosis Prevention Centre, Department of   Molecular Medicine  ‘Sapienza’ University of Rome, Italy

1430-1500   Future therapeutic options for patients with HoFH.  Dr Handrean   Soran, Consultant Physician and Endocrinologist, Central Manchester   University Hospital, UK.

1500-1530  Managing HoFH in children; challenges and options. Dr Andrew Morris,   Consultant Paediatrician, Central Manchester University Hospitals NHS   Foundation Trust.

1530-1600  Case discussions.

HoFH in children; pheresis as a therapeutic option.

1600  Close


Aegereon, AMGEN, AstraZeneca, Link Medical, Sanofi.

Please download invite below:

Apheresis conference 2014 Manchester

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s